
I-Mab IMAB
Quartalsbericht 2025-Q2
hinzugefügt 21.02.2026
I-Mab DPO 2011-2026 | IMAB
DPO Jährlich I-Mab
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2.24 K | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.24 K | 2.24 K | 2.24 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
405 | $ 0.82 | -3.48 % | $ 4.47 M | ||
|
Rigel Pharmaceuticals
RIGL
|
97.9 | $ 33.23 | -4.03 % | $ 584 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
235 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
529 | $ 163.7 | -1.61 % | $ 8.14 B | ||
|
BridgeBio Pharma
BBIO
|
399 | $ 64.66 | -1.37 % | $ 12.4 B | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Avid Bioservices
CDMO
|
62.3 | - | - | $ 789 M | ||
|
Certara
CERT
|
7.85 | $ 7.16 | 1.49 % | $ 1.15 B | ||
|
Caladrius Biosciences
CLBS
|
51.2 | - | -16.75 % | $ 25.8 M | ||
|
Clovis Oncology
CLVS
|
236 | - | -7.23 % | $ 13 M | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Catalyst Pharmaceuticals
CPRX
|
58.1 | $ 24.0 | 0.5 % | $ 2.93 B | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Codexis
CDXS
|
98.4 | $ 0.99 | -3.28 % | $ 72.7 M | ||
|
CTI BioPharma Corp.
CTIC
|
306 | - | - | $ 1.2 B | ||
|
Cyclacel Pharmaceuticals
CYCC
|
1.79 K | - | -5.98 % | $ 34.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.79 K | - | -4.36 % | $ 27 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.2 K | - | - | $ 2.18 B | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Eton Pharmaceuticals
ETON
|
62.3 | $ 17.54 | -3.36 % | $ 450 M | ||
|
Evofem Biosciences
EVFM
|
897 | - | 7.55 % | $ 38.1 M |